Sanyou Biopharmaceuticals is a leading international High-tech biotechnology company focused on research, development and providing integrated solutions for innovative antibody drug developments.
Sanyou Bio is committed to building world-leading antibody drug discovery and development platforms of high-quality, high-throughput, integrated R&D and value transformation. Sanyou Bio is dedicated in constructing a business ecosystem for therapeutic, R&D and diagnostic products and services, and collaborating with global biopharmaceutical, diagnostic, R&D companies to open a new era for the diagnosis and treatment of human diseases.
Since the founding in the year of 2015, Sanyou Bio has been growing rapidly. As of May 2021, Sanyou Bio has a professional team of more than 160 employees, of which more than 70% hold a PhD or master degree, and this team is deeply experienced in R&D and industrialization of innovative drugs. Sanyou Bio has established an integrated R&D laboratory of several thousands of square meters with advanced facilities in Caohejing Hi-Tech Park in Shanghai. The laboratory have 10 functional modules and more than 40 core technology platforms, led by a series of super-trillion phage display antibody libraries, and followed by a full range of essential R&D platforms for innovative antibody drug discovery, antibody engineering, in vitro and in vivo efficacy screening, pharmaceutical properties analysis, cell line construction, and process development. Sanyou Bio continues to provide new technologies, new products, services and solutions of "best quality, fastest speed and lowest cost". Sanyou Bio has established friendly business relationships with more than 100 pharmaceutical companies, drug development organizations and diagnostic product development companies around the world.
"Excellence and innovation, pursuit of dreams, striving and evolving, for the benefit of patients", holding these principles and beliefs, Sanyou Bio looks forward to working with our customers and partners to build a long-term synergistic growth ecosystem and a healthy society.
Sanyou Bio focuses on the early stage of research and development of the discovery of antibody drug, from "antigen and antibody production" to "animal pharmacodynamic screening", and provides integrated antibody drug development services. Our core business includes internationally advanced and domestically leading technology sub-platforms, such as "integrated protein expression and antigen preparation", "diversified antibody production", "innovative antibody engineering", "systematic antibody drug functional screening", "high-efficiency antibody drugability evaluation", "large-capacity phage display fully human antibody library", "integrated innovative monoclonal antibody drug discovery" can meet the various needs of early development of antibody drugs.
Sanyou Bio has a highly educated core team of scientific research professionals. As an innovative enterprise with antibody R&D as its core, Sanyou Bio has gathered outstanding talents from across the world. They have worked together to build the rapid development of Sanyou Bio and the realization of its great dreams. Our team members are young, energetic, innovative, and brave enough to face the challenges of advancing science forward.
In 2017, as part of the “over 100 billion capacity fully human antibody library” cooperation plan, our technical team made use of our unique advantages to construct a world-leading antibody library to assist global scientific research and benefit society.
Our antibody technology team works for the company's antibody customization and antibody library development. Our team members have on average Three years of experience in antibody technology research and development. Since the establishment of this team, hundreds of related services have been successfully delivered.
Our team are skilled innovators,difficulties and never give up while focused on their goals. Their first-class technical abilities and innovative spirit ensure the rapid growth of R&D to expand the company's antibody libraries.
State-of-the Art Laboratories
Our company has more than 430 instruments including AKTA, HPLC, flow cytometers, Fortebio protein interaction analyzers, magnetic bead high-throughput screening systems, multi-function microplate readers, micro-organism and mammalian cell electro-transfection instruments among other first-class instruments and equipment. Sanyou Bio has all the instruments and equipment needed for molecular biology, protein expression and purification, cell strain construction, antibody drug functional screening, antibody engineering and antibody physicochemical analysis.
Sanyou Bio has received numerous social and academic awards based on the success of our science platforms and technical services: